Adenosine Deaminase Deficiency Clinical Trial
Official title:
An Observational Long-term Follow-up Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency (ADA-SCID)
This observational long-term follow-up study is designed to collect safety and efficacy data from ADA-SCID patients previously treated with autologous ex vivo gene therapy products based on the EFS-ADA LV encoding for human adenosine deaminase (ADA) gene (EFS-ADA LV), as part of the OTL-101 clinical development program. No investigational medicinal product will be administered to these patients as part of the OTL-101-6 study.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01279720 -
Gene Therapy ADA Deficiency
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT05300334 -
Investigation of ADA Enzyme Deficiency
|
||
| Completed |
NCT01380990 -
Lentiviral (LV) Gene Therapy for Adenosine Deaminase (ADA) Deficiency
|
Phase 1/Phase 2 | |
| Completed |
NCT03878069 -
Registry Study of Revcovi Treatment in Patients With ADA-SCID
|
||
| Active, not recruiting |
NCT05300347 -
Observational Study Evaluating the Prevalence of Enzyme Deficiency in Pulmonology Clinics (ADA)
|
||
| Completed |
NCT01420627 -
EZN-2279 in Patients With ADA-SCID
|
Phase 3 | |
| Enrolling by invitation |
NCT05300373 -
Evaluation of Adenosine Deaminase (ADA) Enzyme Deficiency in Patients With Lymphopenia and/or Elevated Immunoglobulin E
|
||
| Completed |
NCT02022696 -
Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral Vector
|
Phase 1 | |
| Completed |
NCT00008450 -
Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant
|
Phase 1 |